🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’re excited to announce that we have been listed as one of C&EN (Chemical & Engineering News)’s 10 Start-Ups to Watch. Out of over 200 companies, we’re honored to have been selected for our promising #science and the impact it will have on #DrugDiscovery. Thank you Lisa Jarvis! cen.acs.org/business/start…

We're excited to announce that we are a nominee for the 2021 Emerging Life Science Company of the Year at the The New England Venture Capital Association MARVELous NEVYs! We’re looking forward to attending the event on December 2nd and celebrating at the Citizens House of Blues Boston. Learn more here: newenglandvc.medium.com/new-england-ve…

We are thrilled to announce the appointment of Dr. Harvey J Berger, a physician-scientist and biotech-industry veteran with 35 years of experience, as our new chairman and chief executive officer. For full details and to learn more about Dr. Berger: bwnews.pr/3TN3yIv

Yesterday at JPM Healthcare Week our new CEO Harvey J. Berger, M.D. spoke with BiotechTV founder Brad Loncar. Listen to their conversation, here:

Kojin therapeutics is harnessing groundbreaking discoveries in cell-state and #ferroptosis #biology and cutting-edge #drugdiscovery to develop first-in-class treatments for use in patients with #cancer and other diseases –and we are #hiring. #biotechnology bit.ly/4aL0eDv

At Kojin Therapeutics, we are dedicated to building a #collaborative team and allowing them to flourish in an energetic environment. We know that groundbreaking science takes cohesive teamwork. Come join us. kojintx.com/join-us/ #Hiring #drugdiscovery #biotechnology

We are hiring Molecular Cell Biologists and Chemical Biologists. Join the innovative Kojin Therapeutics #drugdiscovery team developing first-in-class medicines for patients with #cancer and other difficult-to-treat diseases. Apply now: bit.ly/4aobQv3 #hiring #biologists

Kojin Therapeutics is hiring Medicinal/Organic Chemists. Learn more about the positions and our team harnessing groundbreaking discoveries in cell-state and ferroptosis biology: bit.ly/3JZFWKL #hiring #Biotech #Chemists

We are looking for talented #Pharmacologists to work in our #collaborative environment advancing novel small-molecule therapeutics that modulate ferroptosis. View our open roles for Preclinical In Vivo and Molecular Pharmacologists: bit.ly/4aL0eDv

Kojin Therapeutics is #Hiring. We are looking for a team member with deep knowledge of state-of-the-art computational chemistry techniques, deployed to accelerate small-molecule drug discovery. Learn more about this position here: bit.ly/3QKoSfx #Chemists #Biotech

We welcome Dr. Benjamin Neel to the Kojin Tx SAB. His expertise in #cancer biology and #cellsignaling will help us translate the latest discoveries in human #celldeath mechanisms to #ferroptosis inducers and inhibitors. #drugdiscovery Ferroptosis (SPP 2306) Cold Spring Harbor Asia

We welcome Eric Winer, MD of Yale Cancer Center to the Kojin Tx SAB. His wealth of clinical-research experience will greatly impact our development of #ferroptosis modulating medicines for patients with #cancer. #breastcancer #drugdiscovery #redoxbiology Ferroptosis (SPP 2306) Cold Spring Harbor Asia

Our founding SAB chair Stuart Schreiber has a special view of our #drugdiscovery, having led the initial work on #cancer #ferroptosis susceptibility at Chemical Biology at the Broad Institute and now the founder of Arena BioWorks. He joins us in welcoming Eric Winer, MD & Benjamin Neel to our SAB.

➡️Join our next BCDI meeting for exciting discussions on targeting cell death for radiation therapy (Henning Willers, MD, FASTRO from Mass General Cancer Center) and breast cancer metastasis (lab of Judith Agudo from Dana-Farber)! Monday Oct 7th at 3PM on the Harvard Med Quad. BostonCellDeath.org

Next week: join hundreds of thought leaders across #pharma #biotech #government #academia #healthcare & # investing for two engaging days of discussion and networking at #BostonCEO. conta.cc/3YuKOPX

A fantastic conversation on optimizing areas for innovation and accelerating #drugdiscovery. Thank you Harvey J. Berger, M.D. @kojintx for leading a wonderful discussion with @excisionbio @cullinantx Magnet Biomedicine & Kestrel Therapeutics